Gene · 8650
Papers2,413
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 2,413
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Signaling pathways governing the maintenance of breast cancer stem cells and their therapeutic implications. | Front Cell Dev Biol | 2023 | 37492224 | PubTator, text mining | PubMed |
| The hidden hedgehog of the pituitary: hedgehog signaling in development, adulthood and disease of the hypothalamic-pituitary axis. | Front Endocrinol (Lausanne) | 2023 | 37476499 | PubTator, text mining | PubMed |
| Evaluation of CD44 Expression in Prostatic Adenocarcinoma: An Institutional Study. | Cureus | 2023 | 37461792 | PubTator, text mining | PubMed |
| Helicobacter pylori-activated fibroblasts as a silent partner in gastric cancer development. | Cancer Metastasis Rev | 2023 | 37460910 | PubTator, text mining | PubMed |
| Structural basis for specific RNA recognition by the alternative splicing factor RBM5. | Nat Commun | 2023 | 37454201 | PubTator, text mining | PubMed |
| Single-cell RNA-seq and bulk RNA-seq explore the prognostic value of exhausted T cells in hepatocellular carcinoma. | IET Syst Biol | 2023 | 37431788 | PubTator, text mining | PubMed |
| PTBP1 promotes hepatocellular carcinoma progression by regulating the skipping of exon 9 in NUMB pre-mRNA. | Heliyon | 2023 | 37408905 | PubTator, text mining | PubMed |
Corrigendum to "Numb/Notch/PLK1 signaling pathway mediated hyperglycemic memory in pancreatic cancer cell radioresistance and the therapeutic effects of metformin" [Cellular Signalling 93 (2022) 110268/CS-D-21-00663R2; doi: 10.1016/j.cellsig.2022.110268]. | Cell Signal | 2023 | 37407424 | PubTator, text mining | PubMed |
| LINC00853 contributes to tumor stemness of gastric cancer through FOXP3-mediated transcription of PDZK1IP1. | Biol Proced Online | 2023 | 37403034 | PubTator, text mining | PubMed |
| Endometrial stem/progenitor cells: Properties, origins, and functions. | Genes Dis | 2023 | 37396532 | PubTator, text mining | PubMed |
| Enhancement of TKI sensitivity in lung adenocarcinoma through m6A-dependent translational repression of Wnt signaling by circ-FBXW7. | Mol Cancer | 2023 | 37393311 | PubTator, text mining | PubMed |
| Ferroptosis-related gene HIC1 in the prediction of the prognosis and immunotherapeutic efficacy with immunological activity. | Front Immunol | 2023 | 37388742 | PubTator, text mining | PubMed |
| α-catenin interaction with YAP/FoxM1/TEAD-induced CEP55 supports liver cancer cell migration. | Cell Commun Signal | 2023 | 37381005 | PubTator, text mining | PubMed |
| A novel risk signature for predicting brain metastasis in patients with lung adenocarcinoma. | Neuro Oncol | 2023 | 37379245 | PubTator, text mining | PubMed |
| Zika Virus Induces Degradation of the Numb Protein Required through Embryonic Neurogenesis. | Viruses | 2023 | 37376558 | PubTator, text mining | PubMed |
| The Intricate Interplay between Cancer Stem Cells and Oncogenic miRNAs in Breast Cancer Progression and Metastasis. | Life (Basel) | 2023 | 37374142 | PubTator, text mining | PubMed |
| Habits, Goals, and Behavioral Signs of Cognitive Perseveration on Wisconsin Card-Sorting Tasks. | Brain Sci | 2023 | 37371397 | PubTator, text mining | PubMed |
| SIX1+PAX3+ identify a progenitor for myogenic lineage commitment from hPSCs. | Development | 2023 | 37366057 | PubTator, text mining | PubMed |
| Discovery of pyrrolo[2,1-f][1,2,4]triazine-based inhibitors of adaptor protein 2-associated kinase 1 for the treatment of pain. | Med Chem Res | 2023 | 37362320 | PubTator, text mining | PubMed |
| How does Nogo receptor influence demyelination and remyelination in the context of multiple sclerosis? | Front Cell Neurosci | 2023 | 37361998 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8650/papers?page=10